Home » Analyst Articles – US
Lifeward (NASDAQ:LFWD) Given New $10.00 Price Target at HC Wainwright
Lifeward (NASDAQ:LFWD – Free Report) had its price objective lifted by HC Wainwright to $10.00 in a report published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, Weiss Ratings... More of this article »
Protagonist Therapeutics (NASDAQ:PTGX) Given New $125.00 Price Target at Citigroup
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its price objective increased by Citigroup from $115.00 to $125.00 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Other... More of this article »
NVIDIA (NASDAQ:NVDA) Price Target Raised to $323.00 at Raymond James Financial
NVIDIA (NASDAQ:NVDA – Free Report) had its price objective raised by Raymond James Financial from $291.00 to $323.00 in a research report released on Thursday,Benzinga reports. The firm currently has a strong-buy rating on the... More of this article »
Progressive (NYSE:PGR) Price Target Raised to $217.00 at Wells Fargo & Company
Progressive (NYSE:PGR – Free Report) had its target price upped by Wells Fargo & Company from $214.00 to $217.00 in a research note issued to investors on Thursday morning,Benzinga reports. Wells Fargo & Company currently... More of this article »
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for HealthEquity (NASDAQ:HQY) Stock Price
HealthEquity (NASDAQ:HQY – Free Report) had its price objective upped by Deutsche Bank Aktiengesellschaft from $120.00 to $128.00 in a research report released on Thursday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft... More of this article »
Amazon.com (NASDAQ:AMZN) Given New $250.00 Price Target at Wolfe Research
Amazon.com (NASDAQ:AMZN) had its price target lowered by Wolfe Research from $255.00 to $250.00 in a research note published on Thursday,MarketScreener reports. The brokerage currently has an outperform rating on the e-commerce giant’s... More of this article »
Oxford Industries (NYSE:OXM) Price Target Cut to $35.00 by Analysts at UBS Group
Oxford Industries (NYSE:OXM – Free Report) had its price objective trimmed by UBS Group from $36.00 to $35.00 in a report published on Thursday,Benzinga reports. The firm currently has a neutral rating on the textile maker’s... More of this article »
Fluence Energy (NASDAQ:FLNC) Rating Increased to Neutral at Guggenheim
Guggenheim upgraded shares of Fluence Energy (NASDAQ:FLNC – Free Report) from a sell rating to a neutral rating in a research note issued to investors on Thursday, Marketbeat Ratings reports. A number of other research analysts... More of this article »
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated by Analysts at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a research report report published on Thursday,Benzinga reports. The firm issued an overweight rating and a $135.00 price... More of this article »
BTIG Research Issues Positive Forecast for Arvinas (NASDAQ:ARVN) Stock Price
Arvinas (NASDAQ:ARVN – Free Report) had its price objective lifted by BTIG Research from $14.00 to $16.00 in a research note released on Thursday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. A... More of this article »
Aligos Therapeutics (NASDAQ:ALGS) Now Covered by Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Aligos Therapeutics (NASDAQ:ALGS – Free Report) in a report released on Thursday, MarketBeat reports. The firm issued a buy rating and a $48.00 price objective on the... More of this article »
Five Below (NASDAQ:FIVE) Upgraded by William Blair to “Outperform” Rating
William Blair upgraded shares of Five Below (NASDAQ:FIVE – Free Report) from a market perform rating to an outperform rating in a report issued on Thursday, Marketbeat.com reports. Other equities analysts also recently issued... More of this article »
MoonLake Immunotherapeutics (NASDAQ:MLTX) Upgraded to Buy at Rothschild & Co Redburn
Rothschild & Co Redburn upgraded shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) from a neutral rating to a buy rating in a research report sent to investors on Thursday, MarketBeat.com reports. Rothschild... More of this article »
Titan America (NYSE:TTAM) Price Target Cut to $19.00 by Analysts at Citigroup
Titan America (NYSE:TTAM – Free Report) had its price target cut by Citigroup from $20.00 to $19.00 in a research report released on Thursday,Benzinga reports. They currently have a buy rating on the stock. A number of other... More of this article »
Paychex (NASDAQ:PAYX) Now Covered by Analysts at Guggenheim
Guggenheim assumed coverage on shares of Paychex (NASDAQ:PAYX – Free Report) in a research note released on Thursday, Marketbeat.com reports. The firm issued a neutral rating on the business services provider’s stock. PAYX... More of this article »
Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $40.00 target price on the stock. Several... More of this article »
J. M. Smucker (NYSE:SJM) Price Target Cut to $113.00 by Analysts at TD Cowen
J. M. Smucker (NYSE:SJM – Free Report) had its price target lowered by TD Cowen from $124.00 to $113.00 in a research report report published on Thursday,Benzinga reports. The firm currently has a hold rating on the stock. A... More of this article »
Nexxen International (NASDAQ:NEXN) Price Target Lowered to $9.00 at BTIG Research
Nexxen International (NASDAQ:NEXN – Free Report) had its price objective lowered by BTIG Research from $10.00 to $9.00 in a research report report published on Thursday,Benzinga reports. The firm currently has a buy rating on... More of this article »
SouthState Bank (NYSE:SSB) Upgraded to “Outperform” at Hovde Group
Hovde Group upgraded shares of SouthState Bank (NYSE:SSB – Free Report) from a market perform rating to an outperform rating in a report released on Thursday morning, Marketbeat reports. Hovde Group currently has $110.00 target... More of this article »
SoFi Technologies (NASDAQ:SOFI) Coverage Initiated by Analysts at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of SoFi Technologies (NASDAQ:SOFI – Free Report) in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. The firm issued an equal weight rating... More of this article »
Freshworks (NASDAQ:FRSH) Downgraded by Oppenheimer to Market Perform
Oppenheimer downgraded shares of Freshworks (NASDAQ:FRSH – Free Report) from an outperform rating to a market perform rating in a report issued on Thursday, MarketBeat reports. Several other research firms also recently issued... More of this article »
Life360 (NASDAQ:LIF) Downgraded to Neutral Rating by DA Davidson
DA Davidson cut shares of Life360 (NASDAQ:LIF – Free Report) from a buy rating to a neutral rating in a report published on Thursday morning, MarketBeat Ratings reports. DA Davidson currently has $40.00 price target on the stock,... More of this article »
ALX Oncology (NASDAQ:ALXO) Now Covered by Analysts at Wells Fargo & Company
Wells Fargo & Company assumed coverage on shares of ALX Oncology (NASDAQ:ALXO – Free Report) in a research note released on Thursday, Marketbeat.com reports. The brokerage issued an overweight rating and a $5.00 price objective... More of this article »
Five Below (NASDAQ:FIVE) Price Target Raised to $235.00 at Citigroup
Five Below (NASDAQ:FIVE – Free Report) had its price objective boosted by Citigroup from $200.00 to $235.00 in a research note issued to investors on Thursday,Benzinga reports. Citigroup currently has a neutral rating on the... More of this article »
CSX (NASDAQ:CSX) Downgraded to In-Line Rating by Evercore
Evercore cut shares of CSX (NASDAQ:CSX – Free Report) from an outperform rating to an in-line rating in a research report released on Thursday morning, MarketBeat.com reports. The brokerage currently has $41.00 price target on... More of this article »
Micron Technology (NASDAQ:MU) Given New $510.00 Price Target at UBS Group
Micron Technology (NASDAQ:MU – Free Report) had its price objective raised by UBS Group from $475.00 to $510.00 in a research report report published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Cipher Mining’s (CIFR) “Buy” Rating Reaffirmed at Rosenblatt Securities
Rosenblatt Securities restated their buy rating on shares of Cipher Mining (NASDAQ:CIFR – Free Report) in a research report report published on Thursday morning,Benzinga reports. Rosenblatt Securities currently has a $24.00... More of this article »
BrightSpring Health Services (NASDAQ:BTSG) Given “Buy” Rating at BTIG Research
BTIG Research restated their buy rating on shares of BrightSpring Health Services (NASDAQ:BTSG – Free Report) in a report released on Thursday,Benzinga reports. They currently have a $55.00 price objective on the stock. BTSG... More of this article »
Cross Country Healthcare (NASDAQ:CCRN) Upgraded to “Outperform” at Wedbush
Wedbush upgraded shares of Cross Country Healthcare (NASDAQ:CCRN – Free Report) from a neutral rating to an outperform rating in a research report report published on Thursday morning, Marketbeat Ratings reports. Wedbush currently... More of this article »
Stoke Therapeutics (NASDAQ:STOK) Receives “Buy” Rating from BTIG Research
BTIG Research reaffirmed their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. BTIG Research currently has a $39.00 price target... More of this article »
Micron Technology (NASDAQ:MU) Lowered to Hold Rating by Summit Insights
Summit Insights cut shares of Micron Technology (NASDAQ:MU – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning, Marketbeat.com reports. Several other research analysts have also issued... More of this article »
Five Below (NASDAQ:FIVE) Given New $285.00 Price Target at UBS Group
Five Below (NASDAQ:FIVE – Free Report) had its target price boosted by UBS Group from $255.00 to $285.00 in a report issued on Thursday morning,Benzinga reports. They currently have a buy rating on the specialty retailer’s... More of this article »
Williams-Sonoma (NYSE:WSM) Price Target Cut to $225.00 by Analysts at TD Cowen
Williams-Sonoma (NYSE:WSM – Free Report) had its price objective cut by TD Cowen from $250.00 to $225.00 in a research report released on Thursday morning,Benzinga reports. They currently have a buy rating on the specialty retailer’s... More of this article »
Arvinas (NASDAQ:ARVN) Price Target Raised to $21.00 at Citigroup
Arvinas (NASDAQ:ARVN – Free Report) had its price objective raised by Citigroup from $18.00 to $21.00 in a report issued on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Several other equities... More of this article »
Vor Biopharma (NASDAQ:VOR) Coverage Initiated by Analysts at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Vor Biopharma (NASDAQ:VOR – Free Report) in a research report report published on Thursday morning, Marketbeat.com reports. The brokerage issued an overweight rating and... More of this article »
SailPoint (NASDAQ:SAIL) Price Target Lowered to $18.00 at BTIG Research
SailPoint (NASDAQ:SAIL – Free Report) had its target price trimmed by BTIG Research from $22.00 to $18.00 in a report published on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. SAIL has... More of this article »
Amgen (NASDAQ:AMGN) Price Target Raised to $390.00 at Wells Fargo & Company
Amgen (NASDAQ:AMGN – Free Report) had its price target lifted by Wells Fargo & Company from $375.00 to $390.00 in a research report report published on Thursday,MarketScreener reports. The firm currently has an equal weight... More of this article »
Maplight Therapeutics (NASDAQ:MPLT) Now Covered by Canaccord Genuity Group
Canaccord Genuity Group started coverage on shares of Maplight Therapeutics (NASDAQ:MPLT – Free Report) in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and... More of this article »
Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $119.00 at Barclays
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its target price upped by Barclays from $113.00 to $119.00 in a report published on Thursday morning,Benzinga reports. They currently have an overweight rating on the stock. Other... More of this article »
Protagonist Therapeutics (NASDAQ:PTGX) Given New $110.00 Price Target at Leerink Partners
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its target price lifted by Leerink Partners from $107.00 to $110.00 in a research note released on Thursday morning,Benzinga reports. They currently have an outperform... More of this article »
Heartflow (NASDAQ:HTFL) Price Target Cut to $35.00 by Analysts at Wells Fargo & Company
Heartflow (NASDAQ:HTFL – Free Report) had its price target lowered by Wells Fargo & Company from $38.00 to $35.00 in a report published on Thursday,Benzinga reports. The firm currently has an overweight rating on the stock. Several... More of this article »
International Business Machines (NYSE:IBM) Given New $290.00 Price Target at BMO Capital Markets
International Business Machines (NYSE:IBM – Free Report) had its price target cut by BMO Capital Markets from $350.00 to $290.00 in a report published on Thursday,Benzinga reports. They currently have a market perform rating... More of this article »
NU (NYSE:NU) Upgraded by UBS Group to “Buy” Rating
UBS Group upgraded shares of NU (NYSE:NU – Free Report) from a neutral rating to a buy rating in a research report report published on Thursday morning, Marketbeat reports. UBS Group currently has $17.60 price target on the stock,... More of this article »
N-able (NYSE:NABL) Given Buy Rating at Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of N-able (NYSE:NABL – Free Report) in a research note published on Thursday,Benzinga reports. Needham & Company LLC currently has a $8.00 price target on... More of this article »
NIKE (NYSE:NKE) Price Target Lowered to $90.00 at BTIG Research
NIKE (NYSE:NKE – Free Report) had its price objective reduced by BTIG Research from $100.00 to $90.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the footwear... More of this article »
NIKE (NYSE:NKE) Price Target Lowered to $58.00 at UBS Group
NIKE (NYSE:NKE – Free Report) had its price target trimmed by UBS Group from $62.00 to $58.00 in a research report report published on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the footwear... More of this article »
Gold Resource (NYSE:GORO) Given New $1.75 Price Target at HC Wainwright
Gold Resource (NYSE:GORO – Free Report) had its target price lowered by HC Wainwright from $2.00 to $1.75 in a research note issued to investors on Thursday morning,Benzinga reports. HC Wainwright currently has a buy rating on... More of this article »
Macy’s (NYSE:M) Price Target Lowered to $20.00 at TD Cowen
Macy’s (NYSE:M – Free Report) had its price objective trimmed by TD Cowen from $21.00 to $20.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has a hold rating on the stock. M has been... More of this article »